Use of exosome transcriptome-based analysis to identify novel biomarkers in patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy

BACKGROUND: The prognosis of esophageal squamous cell carcinoma (ESCC) is improved by neoadjuvant chemoradiotherapy (nCRT), especially for patients with pathologic complete response (pCR). Despite the efforts to predict treatment response using multimodality, no molecule has proven to be a strong bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Zhang, Hong, Liu, Zhichao, Ma, Ning, Li, Chunguang, Wang, Yan, Li, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009568/
https://www.ncbi.nlm.nih.gov/pubmed/36923096
http://dx.doi.org/10.21037/atm-23-452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009568/
https://www.ncbi.nlm.nih.gov/pubmed/36923096
http://dx.doi.org/10.21037/atm-23-452

Ejemplares similares